Azosemide NEW
| Price | $41 | $58 | $89 |
| Package | 25mg | 50mg | 100mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: Azosemide | CAS No.: 27589-33-9 |
| Purity: 99.84% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | Azosemide |
| Description | Azosemide is a potent NKCC1 inhibitor (IC50s: 0.246?μM and 0.197?μM for hNKCC1A and NKCC1B). |
| In vitro | Azosemide inhibits the human sodium-potassium-chloride cotransporter variants hNKCC1B and hNKCC1A [1]. |
| In vivo | Azosemide shows a shorter terminal half-life (50.9% decrease) and MRT (64.1% decrease), smaller AUC (81.9% decrease), faster CL (454% increase), CLNR (307% increase) and CLR (853% increase) for NARs [2]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 250 mg/mL (674.15 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (26.97 mM), Solution. 10% DMSO+90% Saline : < 10 mg/mL (26.97 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. |
| Keywords | sulfonamide | NKCC1B | NKCC1 | NKCC | NaKClcotransporter | Na-K-Cl cotransporter | NaKCl cotransporter | loop | Inhibitor | inhibit | hNKCC1A | diuretic | Azosemide |
| Inhibitors Related | Furosemide-D5 | Bumetanide (Standard) | Bumetanide sodium | KCC2 potentiators-1 | Sodium dichloroacetate | Piretanide | Bumetanide-D5 | Furosemide | Furosemide sodium | ZT-1a | Bumetanide | Torsemide |
| Related Compound Libraries | Bioactive Compound Library | Membrane Protein-targeted Compound Library | ReFRAME Related Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Cardiovascular Disease Compound Library | Anti-Cancer Approved Drug Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Anti-Hypertension Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $41.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-06-02 | |
| $1.00 |
VIP4Y
|
Hebei Dangtong Import and export Co LTD
|
2026-02-25 | |
|
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2025-12-01 | ||
| $1.10 |
VIP6Y
|
Dideu Industries Group Limited
|
2025-11-18 | |
| $50.00 |
Hebei Yanxi Chemical Co., Ltd.
|
2025-06-20 | ||
| $100.00 |
Weijer International Trade (Hebei) Co., Ltd
|
2023-08-16 | ||
| $100.00 |
Henan Bao Enluo International TradeCo.，LTD
|
2023-06-17 | ||
| $25.00 |
XINGTAI XINGJIU NEW MATERIAL TECHNOLOGY CO., LTD
|
2023-03-27 | ||
| $1.00 |
Anhui Rencheng Technology Co., Ltd
|
2023-01-12 | ||
| $100.00 |
Shijiazhuang Suking Biotechnology Co .,Ltd.
|
2022-12-15 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY